0001562180-24-003303.txt : 20240404 0001562180-24-003303.hdr.sgml : 20240404 20240404172906 ACCESSION NUMBER: 0001562180-24-003303 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240402 FILED AS OF DATE: 20240404 DATE AS OF CHANGE: 20240404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Moll Laurent R CENTRAL INDEX KEY: 0001888601 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40960 FILM NUMBER: 24824113 MAIL ADDRESS: STREET 1: C/O ARTERIS, INC. STREET 2: 595 MILLICH DR., SUITE 200 CITY: CAMPBELL STATE: CA ZIP: 95008 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Arteris, Inc. CENTRAL INDEX KEY: 0001667011 STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674] ORGANIZATION NAME: 04 Manufacturing IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 900 E. HAMILTON AVE, SUITE 300 CITY: CAMPBELL STATE: CA ZIP: 95008 BUSINESS PHONE: (408) 470-7300 MAIL ADDRESS: STREET 1: 900 E. HAMILTON AVE, SUITE 300 CITY: CAMPBELL STATE: CA ZIP: 95008 4 1 primarydocument.xml PRIMARY DOCUMENT X0508 4 2024-04-02 false 0001667011 Arteris, Inc. AIP 0001888601 Moll Laurent R C/O ARTERIS, INC. 900 E. HAMILTON AVE., SUITE 300 CAMPBELL CA 95008 false true false false Chief Operating Officer true Common Stock 2024-04-02 4 S false 2206.00 7.0267 D 590872.00 D Common Stock 2024-04-02 4 S false 1985.00 7.0267 D 588887.00 D Common Stock 2024-04-03 4 S false 581.00 7.1721 D 588306.00 D Shares sold to satisfy the Reporting Person's tax liability arising as a result of the release of restricted stock units. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on March 16, 2023. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.59 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes 411,017 restricted stock units. /s/ Paul Alpern, as Attorney-in-Fact for Laurent R. Moll 2024-04-04